Trial Identification, Inclusion, and Exclusion Krista M. Dale et al, JAMA. 2006; 295: 74-80.

Slides:



Advertisements
Similar presentations
Literature Search Strategy Used for the MEDLINE Database Gami AS, et al. J Am Coll Cardiol 2007;49:
Advertisements

Trends in incidence and mortality, England 1989 to 2010.
Trial profile Fox K et al. Lancet 2008;372:
ESH 2004 Paris1 Blood Pressure Control by Home Monitoring A Meta-Analysis of Randomised Trials FP Cappuccio, SM Kerry, L Forbes, A Donald Published in:
Trends in incidence and mortality, England 1988 to 2008.
Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:
A systematic meta-analysis of randomized controlled trials for adjuvant chemotherapy for localized resectable soft-tissue sarcoma Nabeel Pervaiz Nigel.
Nearly 5 Million Americans Have CHF 400,000 new onset cases diagnosed annually 1400,000 new onset cases diagnosed annually 1 Over 250,000 deaths annually.
Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:
Flow of Participants Through the Trial David J. A. Jenkin et al. JAMA 2008;300:
Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:
Early Effects of Resident Work-Hour Restrictions on Patient Safety: A Systematic Review and Plea for Improved Studies by Keith Baldwin, Surena Namdari,
Characteristics of Large Prospective Randomized Controlled Statin Trials Included in the Present Analysis Alawi A. Alsheikh-Ali, et al. JACC 2007;50:
Flow diagram of the systematic literature search indicating the inclusion and exclusion process of studies Liakopoulos OJ, et al. Eur Heart J 2008;29:
Reduced Lung Cancer Mortality Risk Among Breast Cancer Patients Treated With Anti- Estrogens Rapiti E et al. SABCS 2009;Abstract 35.
Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:
Baseline Characteristics of the Patients* - Part I The ONTARGET Investigators. N Engl J Med 2008 [Epub on Mar 31]
TLR Funnel plot (according to outcomes) for studies included in the meta-analysis Death A TVR B MACE DC SE(log OR)
Process of study selection F. Sofi, et al. BMJ 2008 Sep 11;337:a1344.
Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:
Trial profile Mann JF et al. Lancet 2008;372:
Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:
Viscosupplementation for Osteoarthritis of the Knee by David Jevsevar, Patrick Donnelly, Gregory A. Brown, and Deborah S. Cummins J Bone Joint Surg Am.
Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Breastfeeding of Newborns by Mothers Carrying Hepatitis.
Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:
Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:
Am J Nephrol 2013;38: DOI: / Fig. 1. Study selection process.
Trends in incidence and mortality, England 1989 to 2010
CHOICE: Relative risk of death on peritoneal dialysis vs hemodialysis
INCIDENCE.
Meta-analysis of randomised phase III clinical trials comparing EGFR tyrosine kinase inhibitor (TKI) shows that male patients with non-small cell lung.
Low-level laser therapy for neck pain
Nat. Rev. Cardiol. doi: /nrcardio
Dose-response plots of the relation between the intake of the “Healthy” dietary pattern and prostate cancer risk in the different studies included in the.
Male patients with non-small cell lung cancer (NSCLC) have a 24% reduction in the risk of disease progression (A). Male patients with non-small cell lung.
Jun M, et al. Lancet 2010 Epub May 10
Motivational interviewing: a systematic review and meta-analysis
The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.
Forest plot displaying the effect estimates comparing azithromycin and placebo treatment in subgroups defined by above (>0.39 ng·mL−1) or below (
Funnel plot of the 17 trials comparing haloperidol and placebo in schizophrenia (outcome: response rate). Funnel plot of the 17 trials comparing haloperidol.
Cumulative incidence of (A) ESRD, (B) all-cause death, (C) all-cause death without ESRD and (D) ESRD or all-cause death in patients with T1DM diagnosed.
Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,
Literature Flow to Assess the Effects of Omega-3 Fatty Acid on Tumor Incidence Catherine H. MacLean, et al, JAMA. 2006; 295:
Flow of Patients Through the Trial
Baseline Characteristics According to Sex
Flow of Patients Through Trial
Flow diagram for exclusions of trials identified RCT indicates randomized controlled trial Hulten E, et al. Arch Intern Med 2006;166:
Study Participant Flow
Flow Diagram of the Trial Selection Process
Coverage plots of H3K27ac ChIP-seq data in endometrial cancer specimens. Coverage plots of H3K27ac ChIP-seq data in endometrial cancer specimens. For the.
Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.
Baseline Characteristics
Patient Disposition James A. de Lemos et al. JAMA 2004; 292:
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Study Identification and Selection Process
Participation in Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Hisao Ogawa et al. JAMA 2008;300:
Characteristics of Large Randomized Controlled Statin Trials Included in the Present Analysis Alawi A. et al. JACC 2008 Aug 20 [Epub ahead of print]
Baseline Characteristics by hs-CRP
Coverage plots of H3K27ac ChIP-seq data in breast cancer specimens.
CAPP2: Time to first colorectal cancer in those randomized to aspirin compared with those randomized to the aspirin placebo. CAPP2: Time to first colorectal.
Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606.
Coverage plots of H3K27ac ChIP-seq data in prostate cancer specimens.
Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:
Treatment response patterns and effect size over time in exclusively placebo-controlled trials. Treatment response patterns and effect size over time in.
Forest plot and pooled estimates of the effect of NAFLD on the risk of incident diabetes in 16 eligible studies, stratified by length of follow-up (FU)
Forest plot from meta-analysis carried out on four studies including high-dose N-acetylcysteine (NAC) treatment a) assessing the relative risk of chronic.
Age-adjusted breast cancer incidence rates in females by age-adjusted HD incidence rates in females 15–34 years of age in 135 populations in the world.
Funnel plots showing SE and effect size (log rate ratio) in trials of exercise for fall prevention undertaken among (A) general community dwellers, (B)
Gastric, lung, and HPV-related cancer incidence and model fits.
Cases of and deaths from prostate cancer, with associated age-standardized incidence and mortality (per men), among Canadian men aged 45 years.
Presentation transcript:

Trial Identification, Inclusion, and Exclusion Krista M. Dale et al, JAMA. 2006; 295: 74-80

Characteristics of Studies Included in the Meta-analysis Krista M. Dale et al, JAMA. 2006; 295: 74-80

Cancer Incidence Krista M. Dale et al, JAMA. 2006; 295: 74-80

Cancer Death Krista M. Dale et al, JAMA. 2006; 295: 74-80

L’Abbe Plots for Cancer Incidence and Cancer Death Krista M. Dale et al, JAMA. 2006; 295: 74-80

Funnel Plots for Cancer Incidence and Cancer Death Krista M. Dale et al, JAMA. 2006; 295: 74-80

Subgroup Analysis Krista M. Dale et al, JAMA. 2006; 295: 74-80